[Clinical use of RU 486: control of the menstrual cycle and effect on the hypophyseal-adrenal axis].
D000019:Abortifacient Agents / Q000008:administration & dosage*; D000021:Abortifacient Agents, Steroidal / Q000008:administration & dosage*; D000029:Abortion, Legal; D000293:Adolescent; D000328:Adult; D004341:Drug Evaluation; D004963:Estrenes / Q000008:administration & dosage*; D005260:Female; D005938:Glucocorticoids / Q000037:antagonists & inhibitors; D006801:Humans; D008598:Menstruation / Q000187:drug effects*; D015735:Mifepristone; D010913:Pituitary-Adrenal System / Q000187:drug effects*; D011247:Pregnancy; D011374:Progesterone / Q000037:antagonists & inhibitors; D013997:Time Factors
D000019:Abortifacient Agents; D000021:Abortifacient Agents, Steroidal; D004963:Estrenes; D005938:Glucocorticoids; D015735:Mifepristone; D011374:Progesterone
Utilisation clinique du RU 486: contrôle du cycle menstruel et effet sur l'axe hypophyso-surrénalien.